Skip to content
Study details
Enrolling now

A Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers

Applied Biologics, LLC
NCT IDNCT07159282ClinicalTrials.gov data as of Apr 2026
Phase

Phase 4

Target enrollment

60

Study length

about 2 years

Ages

18+

Locations

1 site in FL

What this study is about

This trial is testing whether a single layer placental-based allograft (XWRAP) helps heal nonhealing diabetic foot ulcers compared to standard care. Patients with nonhealing diabetic foot ulcers who are enrolled in another trial may be eligible for this trial if they don't improve with the other treatment.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.XWRAP

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
All receive treatment

Everyone gets the investigational treatment.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Secondary: Adverse Events, Pain, Enjoyment of Life, and General Activity Scale, Time to Closure, Wound Quality of Life

Body systems

Endocrinology